XTL Biopharmaceuticals Sponsored ADR(XTLB)
$1.66-0.05 (-2.64%)
XTLB
XTL Biopharmaceuticals Sponsored ADR Revenue
$1.66
At close:-0.05 (-2.64%)
Want to see XTLB full AI Analyst Report?
XTL Biopharmaceuticals Sponsored ADR (XTLB) Revenue
148 Followers
XTL Biopharmaceuticals Sponsored ADR Revenue
XTL Biopharmaceuticals Sponsored ADR had a revenue of 289.00K in the quarter ending Dec 31, 2024, with 78.40%. This bring the company's revenue in the last twelve months to 451.00K, Increased 178.40%. In the fiscal year ending Dec 31, 2025, XTL Biopharmaceuticals Sponsored ADR had annual revenue of 0.00 with -100.00% growth.
- Revenue (ttm)
- 451.00K
- Revenue Growth
- ―
- P/S Ratio
- ―
- Revenue/Employee
- $0
- Employees
- 10
- Market Cap
- $7.34M
Revenue Chart
XTL Biopharmaceuticals Sponsored ADR Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 0.00 | -451.00K | -100.00% |
| Dec 31, 2024 | 451.00K | 451.00K | ― |
| Dec 31, 2023 | 0.00 | 0.00 | ― |
| Dec 31, 2022 | 0.00 | 0.00 | ― |
| Dec 31, 2021 | 0.00 | 0.00 | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.